Based on a pooled post hoc analysis of Simtriyo‡ vs placebo at Day 42 in adults 18-55.3,4
Endpoints were not controlled for multiplicity.
text-brand-navy
font-weight-medium
size-medium
link-underline-red
8
8
0
false
text-brand-navy
font-weight-medium
size-small
link-underline-red
image
Change in ASRS in adults with Simtriyo graph
false
left
bottom
40
24
0
‡There are no expected differences in effectiveness of the low and high doses of the adult study formulation compared to Simtriyo 210 mg and 280 mg once daily, respectively, for the treatment of ADHD.[br-d][br-m]ASRS=Adult ADHD Self-Report Scale.
text-brand-navy
font-weight-medium
size-website-caption
link-underline-red